JB Chemicals Shares Slip 2% As Q4 Profit Declines 31% YoY; Announces ₹9.30 Final Dividend 

Synopsis: J B Chemicals & Pharmaceuticals Ltd reported a subdued performance in Q4 FY26 as the company witnessed a decline in revenue and profitability during the quarter. Lower operational margins and pressure on earnings impacted the company’s financial performance despite maintaining healthy long-term return ratios. The company also announced a final dividend of Rs. 9.30 per share for FY26. 

J B Chemicals & Pharmaceuticals Ltd is one of India’s leading pharmaceutical companies engaged in the manufacturing and marketing of formulations, active pharmaceutical ingredients (APIs), and healthcare products. The company has a strong presence in the domestic pharmaceutical market across therapeutic segments such as gastroenterology, hypertension, dermatology, and respiratory care. 

J B Chemicals & Pharmaceuticals Ltd currently has a market capitalization of approximately Rs. 34,833 crore, with the stock trading near Rs. 2,163 per share down by 2% compared to its previous close of Rs. 2,209.

The stock touched a 52-week high of Rs. 2,225 and a 52-week low of Rs. 1,554. The company has a book value of Rs. 259 per share. The stock is currently trading at a P/E ratio of 47.7, while the company reported a healthy ROCE of 25.8% and ROE of 19.2%. 

For the quarter ended March 31, 2026, J B Chemicals & Pharmaceuticals reported revenue from operations of Rs. 904 crore compared to Rs. 949 crore in Q4 FY25, reflecting a decline of around 5% year-on-year. The decline in revenue impacted overall profitability during the quarter. 

Operating profit for Q4 FY26 stood at Rs. 201 crore compared to Rs. 226 crore reported in the corresponding quarter last year. Operating profit margin declined to 22% from 24% in Q4 FY25, indicating pressure on operational efficiency. 

Profit before tax came in at Rs. 135 crore during Q4 FY26 compared to Rs. 193 crore reported in the year-ago quarter. The company reported a consolidated net profit of Rs. 101 crore in Q4 FY26 compared to Rs. 146 crore in Q4 FY25, registering a decline of around 31% year-on-year. 

Q3 FY26 vs Q4 FY26 Performance 

Revenue from operations declined from Rs. 1,065 crore in Q3 FY26 to Rs. 904 crore in Q4 FY26. Operating profit also declined from Rs. 296 crore to Rs. 201 crore during the same period, while operating profit margin fell from 28% to 22%. 

Profit before tax declined from Rs. 267 crore in Q3 FY26 to Rs. 135 crore in Q4 FY26. Similarly, net profit dropped from Rs. 198 crore to Rs. 101 crore sequentially. The decline in quarterly earnings reflects margin pressure and lower operational performance during the quarter. 

Along with its Q4 FY26 results, J B Chemicals & Pharmaceuticals announced a final dividend of Rs. 9.30 per equity share for FY26. The company recommended a final dividend of 930% on the face value of Re.1 per share, subject to shareholders’ approval at the upcoming Annual General Meeting (AGM). The company stated that the dividend, if approved by shareholders, will be paid within 30 days from the date of declaration. 

J B Chemicals & Pharmaceuticals reported a weak Q4 FY26 performance as lower revenue and margin pressure impacted profitability during the quarter. However, the company continues to maintain strong fundamentals supported by healthy return ratios and a well-established pharmaceutical business. The announcement of a Rs. 9.30 final dividend also highlights management’s confidence in the company’s long-term financial position.

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.

The post JB Chemicals Shares Slip 2% As Q4 Profit Declines 31% YoY; Announces ₹9.30 Final Dividend  appeared first on Trade Brains.